Biotech Startup Kanvas Biosciences Raises $12.5 Million to Find Bacteria That Help Fight Cancer

Today, the Colorado Department of Public Health and Environment announced a human infection of avian flu, marking the fourth case linked to the multi-state outbreak in cattle. The infected individual, a dairy worker, experienced only mild symptoms. There is currently no evidence of human-to-human transmission. In response to the avian flu threat, Moderna secured $176 million in federal funding for mRNA vaccines against H5N1, while GSK acquired mRNA vaccine candidates from CureVac in a deal worth up to $1.5 billion.

Kanvas Biosciences, a biotech startup, raised $12.5 million to develop therapies utilizing microorganisms discovered through its spatial biology platform to enhance cancer treatments. In other health news, K Health secured $50 million in funding for its AI-powered chatbot, Beacon Therapeutics raised $170 million for gene therapy development, Holoclara received $16 million for autoimmune therapies, and Verona Pharma's ensifentrine was approved by the FDA for COPD treatment. N-Power Medicine raised $72 million for its clinical trial management platform, Walmart sold its virtual care business to Fabric, and Walgreens Boots Alliance plans to reduce its investment in VillageMD. Eli Lilly's Alzheimer's drug donanemab was approved by the FDA, and the Supreme Court will review FDA restrictions on flavored e-cigarette products. A study in JAMA Pediatrics found no major birth defects in babies born to mothers vaccinated with Pfizer or Moderna Covid vaccines in the first trimester.

President Biden proposed new heat protection standards for workers amid rising global temperatures. Additionally, applications to historically black colleges are increasing, top nuclear experts and ex-CIA officials have joined a high school graduate's fusion startup, and Elon Musk's response to Tesla's child labor concerns has been criticized. Novo Nordisk disputed a study linking Ozempic and Wegovy to a rare form of blindness, and a Nature article explores the decline in cancer risk with age. The Washington Post discusses the Supreme Court's impact on U.S. health agencies, while Wired examines weight loss variability with Ozempic.

Join our community to engage in respectful discussions and adhere to our Terms of Service for a safe and informative experience.